| View |
|
DRP-15301
|
Aluminum hydroxide + Magnesium hydroxide +
Oxetacaine
|
Barudon
|
582 mg / 196 mg / 20 mg per 10 mL
|
Oral Suspension
|
Antacid
|
Tai Guk Pharm. Co., Ltd.
|
Korea
|
Initial
|
13 June 2024
|
13 June 2029
|
| View |
|
DRP-15300
|
Losartan Potassium + Amlodipine (as besilate)
|
Zentan AM Forte
|
100 mg/ 10 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium
Channel Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
13 June 2024
|
13 June 2029
|
| View |
|
DRP-15299
|
Losartan Potassium + Amlodipine (as besilate)
|
Besymed
|
50 mg/ 5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB) and Calcium
Channel Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
13 June 2024
|
13 June 2029
|
| View |
|
DRP-15305
|
Paracetamol
|
Healthgard
|
500 mg
|
Tablet
|
Analgesic/Antipyretic
|
Curis Lifesciences Pvt., Ltd.
|
India
|
Initial
|
13 June 2024
|
13 June 2029
|
| View |
|
DRP-14345
|
Ascorbic Acid
|
Cevit
|
500 mg
|
Tablet
|
Vitamin
|
Huazhong Pharmaceutical Co. Ltd.
|
China
|
Initial
|
23 August 2023
|
23 August 2028
|
| View |
|
DRP-10721-07
|
Dapagliflozin
|
Seren 10
|
10 mg
|
Film-Coated Tablet
|
Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
12 June 2024
|
11 November 2026
|
| View |
|
DRP-10946-05
|
Gentamicin (as sulfate)
|
Neogenta
|
Ophthalmic/ Otic Solution (Drops)
|
3mg/mL (0.3% w/v)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
15 June 2024
|
21 December 2026
|
| View |
|
DRP-11028-02
|
Progesterone
|
Froniquiest
|
200 mg
|
Soft Gelatin Oral Capsule
|
Progestogen
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
06 January 2027
|
| View |
|
DRP-11044-08
|
Potassium Citrate
|
Alkacit
|
1080 mg
|
Extended-Release Tablet
|
Antiurolithic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
18 January 2027
|
| View |
|
DRP-11119-02
|
Palonosetron (as hydrochloride)
|
Nausiabene
|
50 mcg / mL (250 mcg / 5 mL)
|
Solution for Intravenous Injection
|
Antiemetic/Antinauseant [Serotonin (5HT3) Antagonist]
|
USV Private Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
04 February 2027
|
| View |
|
DRP-11620-07
|
Febuxostat
|
Febusan
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Gracure Pharmaceutical Ltd
|
India
|
CLIDP Conversion
|
12 June 2024
|
04 April 2027
|
| View |
|
DRP-11636-04
|
Amlodipine (as besilate)
|
Xentravasc 10
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Ratnatris Pharmaceutical Pvt. Ltd.
|
India
|
CLIDP Conversion
|
10 June 2024
|
04 April 2027
|
| View |
|
DRP-11661-07
|
Propofol
|
Primofol
|
10 mg / mL
|
Emulsion for Injection (I.V.)
|
General Anesthetic
|
Daewon Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
14 June 2024
|
07 April 2027
|
| View |
|
DRP-11746-02
|
Paracetamol + Orphenadrine Citrate
|
None
|
450 mg / 35 mg
|
Tablet
|
Analgesic / Antipyretic / Muscle Relaxant
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
10 June 2024
|
26 February 2029
|
| View |
|
DRP-11805-07
|
Co-Amoxiclav
|
Clamoxmed 625
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
|
Yeluri Formulations Pvt Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
05 May 2027
|
| View |
|
DRP-12059-06
|
Sitagliptin (as Phosphate Monohydrate) + Metformin Hydrochloride
|
Si2norm Plus
|
50 mg / 1 g
|
Film-Coated Tablet
|
Oral Hypoglycemic Agent (Dipeptidyl Peptidase 4 (DPP-4) Inhibitor/ Biguanide)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
06 June 2027
|
| View |
|
DRP-12142-02
|
Potassium Chloride
|
Atropos
|
750 mg
|
Extended-Release Tablet
|
Mineral
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
20 June 2027
|
| View |
|
DRP-12192-04
|
Co-Amoxiclav
|
S-Clav
|
457 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillin)
|
J.M. TOLMANN LABORATORIES, INC.
|
Philippines
|
CLIDP Conversion
|
10 June 2024
|
02 September 2027
|
| View |
|
DRP-12279-01
|
Sitagliptin (as phosphate) + Metformin HCl
|
None
|
50 mg/1g
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (Dipeptidyl Peptidase 4 Inhibitor/Biguanide)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
07 July 2027
|
| View |
|
DR-XY49109
|
Telmisartan
|
Telarb
|
40 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Inventia Healthcare Limited
|
India
|
Initial
|
18 June 2024
|
18 June 2029
|